{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:24:45Z","timestamp":1778617485706,"version":"3.51.4"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>There are multiple treatment options for M\u00e9ni\u00e8re's disease (MD), including dietary modifications, aminoglycoside therapy, and surgery. All have limitations, ranging from limited effectiveness to permanent hearing loss. Corticosteroids have long been used to manage MD due to their relative efficacy and tolerability, but the exact mechanism for disease alleviation is uncertain. Until recently, the precise distribution and role that glucocorticoid receptors play in inner ear diseases have remained largely uninvestigated. Several studies propose they influence mechanisms of fluid regulation through ion and water homeostasis. This review will provide an update on the basic science literature describing the activity of endogenous glucocorticoids and exogenous corticosteroids in the inner ear and the relevance to MD, as well as early clinical trial data pertaining to the application of novel technologies for more effective administration of corticosteroids for the treatment of MD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mao.0000000000002467","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T09:40:45Z","timestamp":1575970845000},"page":"271-276","source":"Crossref","is-referenced-by-count":14,"title":["The Physiologic Role of Corticosteroids in Meni\u00e8re's Disease: An Update on Glucocorticoid-mediated Pathophysiology and Corticosteroid Inner Ear Distribution"],"prefix":"10.1097","volume":"41","author":[{"given":"Michael H.","family":"Froehlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230821","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","article-title":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in M\u00e9ni\u00e8re's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc","volume":"113","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R2-20230821","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.otc.2010.05.001","article-title":"Current epidemiology of Meniere's syndrome","volume":"43","author":"Alexander","year":"2010","journal-title":"Otolaryngol Clinic North Am"},{"key":"R3-20230821","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00019052-200402000-00004","article-title":"M\u00e9ni\u00e8re's disease","volume":"17","author":"Minor","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R4-20230821","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00129492-200604000-00011","article-title":"Meniere's disease: prevalence of contralateral ear involvement","volume":"27","author":"House","year":"2006","journal-title":"Otol Neurotol"},{"key":"R5-20230821","first-page":"CD003599","article-title":"Diuretics for M\u00e9ni\u00e8re's disease or syndrome","author":"Thirlwall","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20230821","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/MLG.0b013e31816927f0","article-title":"Medical management of M\u00e9ni\u00e8re's disease","volume":"118","author":"Coelho","year":"2008","journal-title":"Laryngoscope"},{"key":"R7-20230821","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/019459988910000102","article-title":"Natural history vs. surgery for M\u00e9ni\u00e8re's disease","volume":"100","author":"Silverstein","year":"1989","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R8-20230821","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/00129492-200111000-00030","article-title":"Impact of M\u00e9ni\u00e8re's disease on quality of life","volume":"22","author":"Anderson","year":"2001","journal-title":"Otol Neurotol"},{"key":"R9-20230821","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00129492-200107000-00020","article-title":"Patients\u2019 subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in M\u00e9ni\u00e8re's disease","volume":"22","author":"S\u00f6derman","year":"2001","journal-title":"Otol Neurotol"},{"key":"R10-20230821","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/019459989310900408","article-title":"Diuretic and diet effect on M\u00e9ni\u00e8re's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines","volume":"109","author":"Santos","year":"1993","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R11-20230821","first-page":"CD008234","article-title":"Intratympanic gentamicin for M\u00e9ni\u00e8re's disease or syndrome","author":"Pullens","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-20230821","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/lary.25009","article-title":"Management of intractable M\u00e9ni\u00e8re's disease after intratympanic injection of gentamicin","volume":"125","author":"Rah","year":"2015","journal-title":"Laryngoscope"},{"key":"R13-20230821","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000331945","article-title":"Evolution of symptoms in M\u00e9ni\u00e8re's disease","volume":"17","author":"Belinchon","year":"2012","journal-title":"Audiol Neurootol"},{"key":"R14-20230821","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0194599813520398","article-title":"Intratympanic gentamicin for Meniere's disease: short- and long-term follow-up of two regimens of treatment","volume":"150","author":"Casani","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R15-20230821","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/MAO.0b013e318259b3b1","article-title":"Outcomes of intratympanic gentamicin injection to treat M\u00e9ni\u00e8re's disease","volume":"33","author":"Huon","year":"2012","journal-title":"Otol Neurotol"},{"key":"R16-20230821","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/MAO.0b013e31828d655f","article-title":"Control of vertigo after intratympanic corticoid therapy for unilateral M\u00e9ni\u00e8re's disease: a comparison of weekly versus daily fixed protocols","volume":"34","author":"Martin Sanz","year":"2013","journal-title":"Otol Neurotol"},{"key":"R17-20230821","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/mao.0b013e31815dbafc","article-title":"Longitudinal results with intratympanic dexamethasone in the treatment of M\u00e9ni\u00e8re's disease","volume":"29","author":"Boleas-Aguirre","year":"2008","journal-title":"Otol Neurotol"},{"issue":"(7 pt 2)","key":"R18-20230821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","article-title":"Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application","volume":"109","author":"Parnes","year":"1999","journal-title":"Laryngoscope"},{"key":"R19-20230821","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.mao.0000185052.07513.5a","article-title":"Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss","volume":"26","author":"Banerjee","year":"2005","journal-title":"Otol Neurotol"},{"key":"R20-20230821","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","article-title":"Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph","volume":"28","author":"Bird","year":"2007","journal-title":"Otol Neurotol"},{"key":"R21-20230821","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/MAO.0000000000000500","article-title":"Intratympanic dexamethasone as a symptomatic treatment for M\u00e9ni\u00e8re's disease","volume":"35","author":"McRackan","year":"2014","journal-title":"Otol Neurotol"},{"key":"R22-20230821","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5152\/iao.2016.2177","article-title":"Response over time of vertigo spells to intratympanic dexamethasone treatment in Meniere's disease patients","volume":"12","author":"Al Attrache","year":"2016","journal-title":"J Int Adv Otol"},{"key":"R23-20230821","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/S0140-6736(16)31461-1","article-title":"Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re's disease: a randomised, double-blind, comparative effectiveness trial","volume":"388","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"R24-20230821","first-page":"6016","article-title":"Intratympanic dexamethasone injections for refractory Meniere\u2019 s disease","volume":"8","author":"Ren","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R25-20230821","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/01.mlg.0000147919.89357.16","article-title":"Intratympanic injections of dexamethasone for long-term control of vertigo","volume":"114","author":"Barrs","year":"2004","journal-title":"Laryngoscope"},{"key":"R26-20230821","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-5955(89)90013-0","article-title":"Presence of type I and type II\/IB receptors for adrenocorticosteroid hormones in the inner ear","volume":"41","author":"Rarey","year":"1989","journal-title":"Hear Res"},{"key":"R27-20230821","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-5955(92)90021-E","article-title":"Immunochemical detection of glucocorticoid receptors within rat cochlear and vestibular tissues","volume":"60","author":"ten Cate","year":"1992","journal-title":"Hear Res"},{"key":"R28-20230821","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0378-5955(93)90007-N","article-title":"Tissue specific levels of glucocorticoid receptor within the rat inner ear","volume":"64","author":"Rarey","year":"1993","journal-title":"Hear Res"},{"key":"R29-20230821","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-8993(99)02141-1","article-title":"A role of glucocorticoid receptors in the guinea pig vestibular system","volume":"851","author":"Shimogori","year":"1999","journal-title":"Brain Res"},{"key":"R30-20230821","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0194-5998(96)70133-X","article-title":"Receptors for glucocorticoids in the human inner ear","volume":"115","author":"Rarey","year":"1996","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R31-20230821","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.heares.2011.06.003","article-title":"Protecting the auditory system with glucocorticoids","volume":"281","author":"Meltser","year":"2011","journal-title":"Hear Res"},{"key":"R32-20230821","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1089\/neu.2008.0874","article-title":"Glucocorticoid receptor and mitogen-activated protein kinase activity after restraint stress and acoustic trauma","volume":"26","author":"Meltser","year":"2009","journal-title":"J Neurotrauma"},{"key":"R33-20230821","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1210\/en.2006-0260","article-title":"Glucocorticoid receptor and nuclear factor-kappa B interactions in restraint stress-mediated protection against acoustic trauma","volume":"147","author":"Tahera","year":"2006","journal-title":"Endocrinology"},{"key":"R34-20230821","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MAO.0b013e31826a55ad","article-title":"Distribution of glucocorticoid receptors and 11\u03b2-hydroxysteroid dehydrogenase isoforms in the human inner ear","volume":"34","author":"Kumagami","year":"2013","journal-title":"Otol Neurotol"},{"key":"R35-20230821","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/00016489.2017.1280850","article-title":"Effects of early intratympanic steroid injection in patients with acoustic trauma caused by gunshot noise","volume":"137","author":"Chang","year":"2017","journal-title":"Acta Otolaryngol"},{"key":"R36-20230821","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345208","article-title":"Primary observation of early transtympanic steroid injection in patients with delayed treatment of noise-induced hearing loss","volume":"18","author":"Zhou","year":"2013","journal-title":"Audiol Neurootol"},{"key":"R37-20230821","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mce.2007.07.003","article-title":"Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects","volume":"275","author":"Kassel","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R38-20230821","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1677\/JME-08-0015","article-title":"Stimulation of MAPK- phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C\/EBP","volume":"41","author":"Johansson-Haque","year":"2008","journal-title":"J Mol Endocrinol"},{"key":"R39-20230821","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yfrne.2007.10.004","article-title":"The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings","volume":"29","author":"Haller","year":"2008","journal-title":"Front Neuroendocrinol"},{"key":"R40-20230821","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.steroids.2007.12.002","article-title":"Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands","volume":"73","author":"Lowenberg","year":"2008","journal-title":"Steroids"},{"key":"R41-20230821","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.heares.2005.10.006","article-title":"Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear","volume":"212","author":"Trune","year":"2006","journal-title":"Hear Res"},{"key":"R42-20230821","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/ar.22576","article-title":"Corticosteroid therapy for hearing and balance disorders","volume":"295","author":"Trune","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"key":"R43-20230821","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.amjoto.2007.02.005","article-title":"Evaluation of the effect of dexamethasone in experimentally induced endolymphatic hydrops in Guinea pigs","volume":"29","author":"Ozer","year":"2008","journal-title":"Am J Otolaryngol"},{"key":"R44-20230821","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5955(00)00043-5","article-title":"The rat cochlea in the absence of circulating adrenal hormones: an electrophysiological and morphological study","volume":"143","author":"Lohuis","year":"2000","journal-title":"Hear Res"},{"key":"R45-20230821","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000057657","article-title":"Nongenomic effects of corticosteroids on ion transport by stria vascularis","volume":"7","author":"Lee","year":"2002","journal-title":"Audiol Neurootol"},{"key":"R46-20230821","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/MAO.0b013e3181b4ec89","article-title":"Vascular findings in the stria vascularis of patients with unilateral or bilateral M\u00e9ni\u00e8re's disease: a histopathologic temporal bone study","volume":"30","author":"Kariya","year":"2009","journal-title":"Otol Neurotol"},{"key":"R47-20230821","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.heares.2016.01.010","article-title":"Pathophysiology of the cochlear intrastrial fluid-blood barrier (review)","volume":"338","author":"Shi","year":"2016","journal-title":"Hear Res"},{"key":"R48-20230821","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.heares.2018.03.002","article-title":"Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications","volume":"368","author":"Salt","year":"2018","journal-title":"Hear Res"},{"key":"R49-20230821","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00129492-200407000-00010","article-title":"Spiral ligament and stria vascularis changes in cochlear otosclerosis: effect on hearing level","volume":"25","author":"Doherty","year":"2004","journal-title":"Otol Neurotol"},{"key":"R50-20230821","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1432-1033.1997.t01-1-00355.x","article-title":"Function, gene, organization and protein structures of 11\u03b2-hydroxysteroid dehydrogenase isoforms","volume":"249","author":"Oppermann","year":"1997","journal-title":"Eur J Biochem"},{"key":"R51-20230821","doi-asserted-by":"crossref","first-page":"C544","DOI":"10.1152\/ajpcell.00338.2008","article-title":"Regulation of ENaC-mediated sodium transport by glucocorticoids in Reissner's membrane epithelium","volume":"296","author":"Kim","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"R52-20230821","first-page":"72","article-title":"Blood-labyrinth barrier and fluid dynamics of the inner ear","volume":"7","author":"Juhn","year":"2011","journal-title":"Int Tinnitus J"},{"key":"R53-20230821","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.addr.2008.08.001","article-title":"Inner ear drug delivery for auditory applications","volume":"60","author":"Swan","year":"2008","journal-title":"Adv Drug Delivery Rev"},{"key":"R54-20230821","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0173(03)00189-9","article-title":"Disorders of cochlear blood flow","volume":"43","author":"Nakashima","year":"2003","journal-title":"Brain Res Rev"},{"key":"R55-20230821","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/00016488909125524","article-title":"Middle ear effusion induced by various inflammatory mediators and neuropeptides: an experimental study in the rat","volume":"108","author":"Goldie","year":"1989","journal-title":"Acta Otolaryngol"},{"key":"R56-20230821","first-page":"CD008514","article-title":"Intratympanic steroids for M\u00e9ni\u00e8re's disease or syndrome","author":"Phillips","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R57-20230821","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.heares.2013.07.013","article-title":"Gentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in Guinea pigs","volume":"304","author":"King","year":"2013","journal-title":"Hear Res"},{"key":"R58-20230821","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/lary.26562","article-title":"Steroid intracochlear distribution differs by administration method: systemic versus intratympanic injection","volume":"128","author":"Lee","year":"2018","journal-title":"Laryngoscope"},{"key":"R59-20230821","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1916-0216-42-19","article-title":"Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administration","volume":"42","author":"Grewal","year":"2013","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R60-20230821","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11136-011-0028-z","article-title":"The prevalence of hearing impairment and its burden on the quality of life among adults with Medicare Supplement Insurance","volume":"21","author":"Hawkins","year":"2012","journal-title":"Qual Life Res"},{"key":"R61-20230821","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2017.12.010","article-title":"Communication pathways to and from the inner ear and their contributions to drug delivery","volume":"362","author":"Salt","year":"2018","journal-title":"Hear Res"},{"key":"R62-20230821","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1126\/science.1232862","article-title":"Dual origin of the epithelium of the mammalian middle ear","volume":"339","author":"Thompson","year":"2013","journal-title":"Science"},{"key":"R63-20230821","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/00016487509121296","article-title":"Macromolecular transport by the middle ear and its lymphatic system","volume":"80","author":"Lim","year":"1975","journal-title":"Acta Otolaryngol"},{"key":"R64-20230821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2005.04.011","article-title":"In vivo demonstration of the absorptive function of the middle ear epithelium","volume":"210","author":"Li","year":"2005","journal-title":"Hear Res"},{"key":"R65-20230821","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1359-6446(05)03574-9","article-title":"Local inner-ear drug delivery and pharmacokinetics","volume":"10","author":"Salt","year":"2005","journal-title":"Drug Discov Today"},{"key":"R66-20230821","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MAO.0b013e318161aaae","article-title":"Dexamethasone concentration gradients along scala tympani after application to the round window membrane","volume":"29","author":"Plontke","year":"2008","journal-title":"Otol Neurotol"},{"key":"R67-20230821","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.heares.2004.06.003","article-title":"Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig","volume":"196","author":"Takemura","year":"2004","journal-title":"Hear Res"},{"key":"R68-20230821","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0022215111000028","article-title":"Therapeutic efficacy of topical application of dexamethasone to the round window niche after acoustic trauma caused by intensive impulse noise in guinea pigs","volume":"125","author":"Chi","year":"2011","journal-title":"J Laryngol Otol"},{"key":"R69-20230821","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5955(02)00345-3","article-title":"Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig","volume":"167","author":"Himeno","year":"2002","journal-title":"Hear Res"},{"key":"R70-20230821","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2015.08.015","article-title":"Recent advances in local drug delivery to the inner ear","volume":"494","author":"El Kechai","year":"2015","journal-title":"Int J Pharm"},{"key":"R71-20230821","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/00005537-200311000-00008","article-title":"Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops?","volume":"113","author":"Hillman","year":"2003","journal-title":"Laryngoscope"},{"key":"R72-20230821","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/lary.23909","article-title":"Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss","volume":"123","author":"Chou","year":"2013","journal-title":"Laryngoscope"},{"key":"R73-20230821","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/00016480601126952","article-title":"Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment","volume":"127","author":"Van Wijck","year":"2007","journal-title":"Acta Otolaryngol"},{"key":"R74-20230821","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/003655402_000028037","article-title":"Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study","volume":"122","author":"Lefebvre","year":"2002","journal-title":"Acta Otolaryngol"},{"key":"R75-20230821","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/lary.20074","article-title":"Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy","volume":"119","author":"Plontke","year":"2009","journal-title":"Laryngoscope"},{"key":"R76-20230821","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00405-012-2061-0","article-title":"Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss","volume":"270","author":"Li","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R77-20230821","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MAO.0b013e3182009d29","article-title":"OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders","volume":"32","author":"Piu","year":"2011","journal-title":"Otol Neurotol"},{"key":"R78-20230821","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/MAO.0000000000001227","article-title":"Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of M\u00e9ni\u00e8re's disease: randomized phase 2b safety and efficacy trial","volume":"37","author":"Lambert","year":"2016","journal-title":"Otol Neurotol"},{"key":"R79-20230821","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/MAO.0b013e318263d35d","article-title":"A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral M\u00e9ni\u00e8re's disease","volume":"33","author":"Lambert","year":"2012","journal-title":"Otol Neurotol"},{"key":"R81-20230821","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.mao.0000185050.69394.48","article-title":"Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and M\u00e9ni\u00e8re's-associated sudden sensorineural hearing loss","volume":"26","author":"Selivanova","year":"2005","journal-title":"Otol Neurotol"},{"key":"R82-20230821","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2018.05.020","article-title":"Inner ear drug delivery: recent advances, challenges, and perspective","volume":"126","author":"Hao","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"R83-20230821","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/17425247.2015.974548","article-title":"The role of intracochlear drug delivery devices in the management of inner ear disease","volume":"12","author":"Ayoob","year":"2015","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Otology &amp; Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAO.0000000000002467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T23:45:49Z","timestamp":1692661549000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MAO.0000000000002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0000000000002467","relation":{},"ISSN":["1531-7129","1537-4505"],"issn-type":[{"value":"1531-7129","type":"print"},{"value":"1537-4505","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}